See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Fampridine, Fampridine-SR
See also:
Chlorella
What is 4-Aminopyridine (4-AP)?
A drug currently in phase 2 clinical trials for MS, 4-Aminopyridine blocks potassium channels and prolongs action potentials thereby increasing transmitter release at the neuromuscular junction and elsewhere.
Read more...
66 patients in the community are taking or have taken 4-Aminopyridine (4-AP).
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Other | 22 | 37% |
| Fatigue | 10 | 17% |
| Stiffness/spasticity | 7 | 12% |
| Mobility | 5 | 8% |
| Slow my MS progress | 4 | 6% |
| disease-related symptoms | 3 | 5% |
| Numbness in my hands, arms, legs, and waist | 1 | 1% |
| Brain fog | 1 | 1% |
| I walk slower tire more easily | 1 | 1% |
| Neuropathy pain | 1 | 1% |
| Sensation | 1 | 1% |
| Weakness in legs | 1 | 1% |
| Uhthoff's phenomenon | 1 | 1% |
Based on the patients currently taking 4-Aminopyridine (4-AP).
Top 10 (Show all)
All (Show Top 10)
How long current patients have been taking 4-Aminopyridine (4-AP) or how long patients were taking 4-Aminopyridine (4-AP) before stopping.
Results from 6 patient evaluations. See the overall results and all individual evaluations.
| Major | 50% | 2 |
|---|---|---|
| Moderate | 50% | 2 |
Other
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 17% | 1 |
| Mild | 17% | 1 |
| None | 67% | 4 |
Top reported side-effects include: Anxiety, Nausea, Dizziness/feeling like passing out
Summary results are based on 6 individual responses. For more information, see overall results for Adherence, Burden and Cost.